Esperion Therapeutics reported $596.26M in Market Capitalization for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Market Capitalization Change
Abbvie ABBV:US $ 198.95B 7.96B
Acceleron Pharma XLRN:US $ 7.62B 606.02M
Adamas Pharmaceuticals ADMS:US 239.75M 41.19M
Alexion Pharmaceuticals ALXN:US $ 33.78B 393.15M
Alnylam Pharmaceuticals ALNY:US $ 19.93B 3.36B
Amarin AMRN:US 1.73B 715.38M
Amgen AMGN:US $ 140.05B 3.22B
Arena Pharmaceuticals ARNA:US $ 4.16B 41.38M
Biogen BIIB:US $ 42.17B 9.96B
Biomarin Pharmaceutical BMRN:US $ 14.17B 1.08B
Cytokinetics CYTK:US $ 1.42B 244.24M
Daiichi Sankyo 4568:JP 4662.17B 2197.51B
Eli Lilly And LLY:US $ 221.02B 902.49M
Esperion Therapeutics ESPR:US $ 596.26M 193.51M
Flexion Therapeutics FLXN:US $ 411.02M 35.8M
Geron GERN:US $ 449.18M 54.1M
Halozyme Therapeutics HALO:US $ 6.47B 491.5M
Heron Therapeutics HRTX:US $ 1.58B 98.85M
Intercept Pharmaceuticals ICPT:US $ 663.03M 98.97M
Intra Cellular Therapies ITCI:US $ 3.32B 573.64M
IONIS PHARMACEUT IONS:US $ 5.62B 710.4M
Merk MRK:US $ 196918.18M 1780.24M
Minerva Neurosciences NERV:US $ 99.11M 25.63M
Moderna Inc MRNA:US $ 94.35B 41.95B
Nektar Therapeutics NKTR:US $ 3.13B 515.22M
Pfizer PFE:US $ 219205.69M 17108.81M
Ptc Therapeutics PTCT:US $ 2.98B 347.22M
Puma Biotechnology PBYI:US $ 370.52M 20.79M
Regeneron Pharmaceuticals REGN:US $ 59.5B 8.81B
Sanofi SAN:FP 111.4B 5.33B
Sarepta Therapeutics SRPT:US $ 6.2B 282.45M
Seattle Genetics SGEN:US $ 28.65B 3.48B
United Therapeutics UTHR:US $ 8.04B 550.55M
Vanda Pharmaceuticals VNDA:US $ 1.2B 370.85M
Zogenix ZGNX:US $ 964.44M 125.02M